When is Glycin clinically relevant?
Glycin is most useful when it is interpreted together with the symptom pattern, the relevant category context, and the broader diagnostic question behind the test.
Glycine is the simplest amino acid, involved in protein synthesis, neurotransmission, and detoxification. This test measures glycine levels in blood or urine to evaluate amino acid metabolism.
Glycin should not be read as an isolated number only. This short overview summarizes when the marker matters, which questions it does not answer on its own, and what broader context makes the result more useful.
Glycin is most useful when it is interpreted together with the symptom pattern, the relevant category context, and the broader diagnostic question behind the test.
Glycin does not replace symptom timing, functional assessment, or the wider clinical picture. A marker may be informative without being the whole answer.
The next useful step is usually to connect Glycin to related markers, symptoms, and the broader context of the test rather than reading it as an isolated endpoint.
Glycine is a non-essential amino acid that serves as a building block for proteins and plays key roles in the central nervous system as a neurotransmitter. It is also essential for the synthesis of heme, creatine, bile acids, and glutathione. Measuring glycine levels helps assess amino acid metabolism and can aid in the investigation of suspected metabolic disorders or nutritional status.
A glycine level below the reference range (typically 120–350 µmol/L or 0.9–2.6 mg/dL, lab-dependent) may suggest inadequate dietary protein intake or malnutrition. Rare metabolic conditions that impair glycine synthesis or increase its breakdown can also lead to low levels. Since glycine is involved in many pathways, low levels are often evaluated alongside other amino acids.
An elevated glycine level above the reference range (typically 120–350 µmol/L or 0.9–2.6 mg/dL, lab-dependent) may indicate a disorder such as nonketotic hyperglycinemia (glycine encephalopathy), a rare genetic condition. High levels can also be associated with diabetes, obesity, or certain medications. Transient elevations can occur after a high-protein meal, so fasting values are important.
This result is not specific for ME/CFS or Long COVID. Read it together with the clinical question, symptoms, related findings and the laboratory reference range rather than in isolation.
Practical details are separated from the general FAQ so they are easier to find.
Glycine is tested to evaluate amino acid metabolism, often when a healthcare provider suspects a metabolic disorder or nutritional deficiency. It can also be part of a broader panel to assess liver function or neurological symptoms, given its role as a neurotransmitter.
Glycin is most useful when it is interpreted together with the symptom pattern, the relevant category context, and the broader diagnostic question behind the test.
The next useful step is usually to connect Glycin to related markers, symptoms, and the broader context of the test rather than reading it as an isolated endpoint.
You now know which questions can matter when reading this result. With Elara you can keep the value and its surrounding context together over time.
Save the lab value with its date so individual measurements do not get lost.
See previous measurements together instead of relying on a single snapshot.
View Glycine alongside symptom, energy, sleep and PEM entries without assuming one caused the other.
Export your history as a PDF — structured for the next check-up.
Normal glycine levels in blood typically range from 120 to 350 µmol/L (about 0.9 to 2.6 mg/dL), but this range is lab-dependent and can vary based on the testing method and population. Results should be interpreted alongside other amino acids and clinical findings.
A high glycine level may suggest nonketotic hyperglycinemia, a rare inherited disorder, or could be associated with diabetes, obesity, or certain medications. Transient increases can result from a recent high-protein meal, so fasting samples are preferred for accuracy.
Low glycine levels are less common but may indicate insufficient dietary protein or malnutrition. They can also occur in rare metabolic disorders that affect glycine production or increase its breakdown. A low result is typically considered in the context of a full amino acid profile.
Glycin does not replace symptom timing, functional assessment, or the wider clinical picture. A marker may be informative without being the whole answer.
This biomarker gains value when it is connected to symptom patterns, daily function, and structured self-observation instead of being read in isolation.
Reduced capacity, multisystem symptoms, and delayed worsening often make more sense when the broader ME/CFS pattern is considered.
Markers linked to sleep, stress, recovery, hormones, or metabolism often become more useful when viewed through pacing and daily load management.
Questionnaires help connect biomarkers to symptom patterns, functional limits, and patient-reported change over time.
Markers from the same system can add useful context when a single lab value is hard to interpret on its own.
No individual medical review is documented.
This English content was created with AI assistance and automatically validated. This is not an individual medical review.
This information does not replace medical advice. Lab values should be assessed in the context of your medical history, the reason for testing and other findings. Elara provides health information for orientation — not diagnoses or treatment decisions.
Bring your lab values, symptoms and energy into one shared context — so you walk into your next appointment more informed and structured.